Skip to main content
. 2022 Jan 23;11(2):143. doi: 10.3390/antibiotics11020143

Figure 3.

Figure 3

The annual consumption of the individual carbapenem, the percentage of susceptibility and the MDR-P. aeruginosa data from the sputum and the BAL specimens from the non-ICU wards. %S IPM = the percentage of susceptibility to imipenem. %S MEM = the percentage of susceptibility to meropenem.